Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vs oral finasteride plus minoxidil in male androgenetic alopecia
ChiCTR2600119739Phase 4Recruiting
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of finasteride and minoxidil in androgenetic alopecia (AGA) (2 arms), sponsored by Beijing Tsinghua Changgung Hospital. Primary endpoint: Change in hair count (TAHC) at week 24. Started Mar 2026; status: recruiting.
02
Drugs
finasterideminoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ChiCTR2600119739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119739.